In re: Allergan Erisa v., No. 18-2729 (3d Cir. 2020)
Annotate this CaseThis opinion or order relates to an opinion or order originally issued on September 18, 2020.
Download PDF
UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT _____________ No. 18-2729 _____________ In re: ALLERGAN ERISA LITIGATION ANDREW J. ORMOND, on behalf of the Allergan, Inc. Savings and Investment Plan, the Actavis, Inc. 401(k) Plan, himself, and a class consisting of similarly situated participants of the Plan; JACK XIE, Appellants _______________ On Appeal from the United States District Court for the District of New Jersey (D.C. Nos. 2:17-cv-01554 & 2:17-cv-05070) District Judge: Honorable Susan D. Wigenton _______________ ORDER AMENDING OPINION (Filed: September 18, 2020) _______________ The opinion filed September 18, 2020 is hereby amended, It has come to the Clerk’s attention that last name for one of appellee’s counsel was misspelled. Counsel for appellee should be correctly listed as Robert D. Towey and not as Robert D. Towry. For the Court, s/ Patricia S. Dodszuweit Clerk Date: September 23, 2020 kr/cc: All Counsel of Record
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
